Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)

Autor: O. Koriakine, P.H.M. de Mulder, G. Kaiser, Alan Horwich, B. Paluchowska, A. van Oosterom, Sophie D. Fosså, R. de Wit, Laurence Collette, L. de Prijck

Publikováno v: British Journal of Cancer
British Journal of Cancer, 93(11), 1209-1214. Nature Publishing Group
British Journal of Cancer, 93, 1209-14
British Journal of Cancer, 93, 11, pp. 1209-14

Item does not contain fulltext New chemotherapy regimens are continuously explored in patients with high-risk malignant germ cell tumours (MGCTs). This multicentre phase II trial assessed the efficacy and toxicity of C-BOP/BEP chemotherapy in interme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a005bc4cda5285f6138b93a09335af23
https://doi.org/10.1038/sj.bjc.6602830

Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer

Autor: B. Paluchowska, O. Koriakine, J. W. Hetherington, A Zurlo, Peter Whelan, P.H.Th.J. Slee, M. Debois, Christine Theodore, L. Collette, K. Vekemans, D. Lebwohl, Cora N. Sternberg, P. van Erps, T. Oliver

Publikováno v: Oncology. 68(1)

Satraplatin is a novel oral platinum (IV) complex that shows activity against hormone-refractory prostate cancer (HRPC) in cisplatin-resistant human tumor lines in phase I and phase II trials [1]. A randomized multicenter phase III trial with a targe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd424752f5a6b7147224325a81c3bb6
https://pubmed.ncbi.nlm.nih.gov/15741753

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.